The city of Charlotte, North Carolina, currently has 4 active clinical trials seeking participants for Dementia research studies.
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Recruiting
PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the benefit of statins for reducing the primary composite of death, dementia, and persistent disability and secondary composites including mild cognitive impairment (MCI) and cardiovascular events.
Gender:
All
Ages:
75 years and above
Trial Updated:
06/14/2024
Locations: Atrium Health, Charlotte, North Carolina
Conditions: Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases
A Cultural Adaptation of the Caregiver TLC Psychoeducational Program to Support Latino Caregivers (CUIDANDO JUNTOS)
Recruiting
This study will test the effectiveness of a behavioral intervention called Cuidando Juntos in Latino caregivers of people with dementia. The study will determine if the intervention improves the caregiver's loneliness, stress, burden, and depression.
Gender:
All
Ages:
39 years and above
Trial Updated:
06/07/2024
Locations: University of North Carolina, Charlotte, Charlotte, North Carolina
Conditions: Caregivers of People With Dementia
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Recruiting
This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2 Study 12-AVR-131 to be included.
Gender:
All
Ages:
Between 50 years and 90 years
Trial Updated:
05/22/2024
Locations: ANI Neurology PLLC dba Alzheimer's Memory Center, Charlotte, North Carolina
Conditions: Agitation in Patients With Dementia of the Alzheimer's Type
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
Recruiting
This trial is a multi-center, double-blind, placebo-controlled, randomized study to evaluate the efficacy and safety of AXS-05 compared to placebo for the treatment of agitation associated with Alzheimer's disease.
Gender:
All
Ages:
Between 65 years and 90 years
Trial Updated:
04/25/2024
Locations: Clinical Research Site, Charlotte, North Carolina
Conditions: Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer Disease, Agitation